Cargando…
Myelodysplastic syndrome: the other cause of anemia in end-stage renal disease patients undergoing dialysis
In end-stage renal disease (ESRD) patients receiving dialysis, anemia is common and related to a higher mortality rate. Erythropoietin (EPO) resistance and iron refractory anemia require red blood cell transfusions. Myelodysplastic syndrome (MDS) is a disease with hematopoietic dysplasia. There are...
Autores principales: | Chang, Min-Yu, Lin, Sheng-Fung, Wu, Shih-Chi, Yang, Wen-Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511931/ https://www.ncbi.nlm.nih.gov/pubmed/32968161 http://dx.doi.org/10.1038/s41598-020-72568-5 |
Ejemplares similares
-
Is there different risk of cancer among end‐stage renal disease patients undergoing hemodialysis and peritoneal dialysis?
por: Lee, Yi‐Che, et al.
Publicado: (2018) -
Effect of peritoneal dialysis versus hemodialysis on renal anemia in renal in end-stage disease patients: a meta-analysis
por: Wang, Wan-Ning, et al.
Publicado: (2016) -
Successful Introduction of Peritoneal Dialysis in an End-stage Renal Failure Patient with Idiopathic Aplastic Anemia
por: Suzuki, Yasuhiro, et al.
Publicado: (2020) -
Erectile Dysfunction and Risk of End Stage Renal Disease Requiring Dialysis: A Nationwide Population-Based Study
por: Shen, Yuan-Chi, et al.
Publicado: (2014) -
Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
por: Xie, Xin, et al.
Publicado: (2023)